Actively Recruiting
Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.
Led by Casa di Cura Dott. Pederzoli · Updated on 2026-02-24
15
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
C
Casa di Cura Dott. Pederzoli
Lead Sponsor
H
Herboplanet Srl
Collaborating Sponsor
AI-Summary
What this Trial Is About
The prospective experimental study aims to take an instantaneous photograph of the subject at time T0 and after 24 hours of intestinal permeability and dysbiosis indices in patients with acute coronary syndromes (ACS) which include unstable coronary artery disease (unstable angina) and acute myocardial infarction (AMI). The aim is to verify whether essential oils in particular formulations with high bioavailability are able to re-establish intestinal eubiosis after 2 months, confirmed by tests laboratory specifics such as metabolomics.
CONDITIONS
Official Title
Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signing of informed consent
- Diagnosis of Acute Coronary Syndrome (ACS)
- Age between 30 and 70 years
You will not qualify if you...
- Use of lipid-lowering drugs (statins, ezetimibe, fibrates) within 3 months before consent
- Use of lipid-lowering nutraceuticals containing monacolin K within 3 months before consent
- Use of monoclonal antibodies inhibiting PCSK9 (e.g., Evolocumab, Alirocumab) within 3 months before consent
- Diagnosis of HIV, cancer, or diabetes type I or II
- Female patients who become pregnant during the trial will be withdrawn
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
Peschiera del Garda, Verona, Italy, 37019
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here